Eikon Therapeutics
Founded Year
2019Stage
Series D | AliveTotal Raised
$1.123BValuation
$0000Last Raised
$350.7M | 1 mo agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-27 points in the past 30 days
About Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company focused on drug discovery and development for life-threatening diseases. The company utilizes technology at the intersection of biology, engineering, and chemistry to create treatments. Eikon's discovery platform includes advanced microscopes that enable molecular-resolution measurements of protein movement in living cells, aiding in the identification of compound-protein interactions and the exploration of biology. It was founded in 2019 and is based in Hayward, California.
Loading...
Loading...
Expert Collections containing Eikon Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Eikon Therapeutics is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,270 items
Eikon Therapeutics Patents
Eikon Therapeutics has filed 1 patent.
The 3 most popular patent topics include:
- biotechnology
- cell imaging
- fluorescent dyes
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/26/2022 | Molecular biology, Microscopy, Cell imaging, Fluorescent dyes, Biotechnology | Application |
Application Date | 7/26/2022 |
|---|---|
Grant Date | |
Title | |
Related Topics | Molecular biology, Microscopy, Cell imaging, Fluorescent dyes, Biotechnology |
Status | Application |
Latest Eikon Therapeutics News
Mar 26, 2025
Eikon Therapeutics, a biotechnology company focused on integrating engineering and molecular biology for drug discovery, has secured $350.7 million in Series D financing. This latest funding round brings the company’s total private investment to over $1.1 billion since its founding in 2019...
Eikon Therapeutics Frequently Asked Questions (FAQ)
When was Eikon Therapeutics founded?
Eikon Therapeutics was founded in 2019.
Where is Eikon Therapeutics's headquarters?
Eikon Therapeutics's headquarters is located at 3929 Point Eden Way, Hayward.
What is Eikon Therapeutics's latest funding round?
Eikon Therapeutics's latest funding round is Series D.
How much did Eikon Therapeutics raise?
Eikon Therapeutics raised a total of $1.123B.
Who are the investors of Eikon Therapeutics?
Investors of Eikon Therapeutics include Lux Capital, Foresite Capital, The Column Group, General Catalyst, Stepstone Group and 17 more.
Loading...
Loading...